Wire Stories
ReViral and LianBio Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Sisunatovir in China
LONDON & RESEARCH TRIANGLE PARK, N.C. & SHANGHAI & PRINCETON, N.J.–(BUSINESS WIRE)–ReViral Ltd., a clinical-stage biopharmaceutical company focused on discovering, developing, and...